Menu
Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
Safety and Feasibility of Low-Dose Apatinib Combined with S-1 as the Second-Line Therapy or Beyond in Chinese Patients with Pulmonary and Hepatic Metastasis of Nasopharyngeal Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,657 | Dovepress* | 5,933+ | 1,010 | 6,943 | |
| PubMed Central* | 724 | 168 | 892 | ||
| Totals | 6,657 | 1,178 | 7,835 | ||
| *Since 30 March 2020 | |||||
View citations on PubMed Central and Google Scholar